Global /India /Healthcare /Drug Manufacturers - General /PPLPHARMA
chevron_leftBack
Piramal Pharma Ltd. logo

Piramal Pharma Ltd.

PPLPHARMA
NSE: PPLPHARMA Delayed
161.87INR 1.1%
1.70 USD
As of 7 June 2026, Piramal Pharma Ltd. has a market cap of $2.22B USD, ranking #6571 globally and #342 in India. It ranks #528 in the Healthcare sector, and #200 in the Drug Manufacturers - General industry.
Global Rank
6571
Country Rank
342
Sector Rank
528
Industry Rank
200
Key Stats
Market Cap
$2.22BUSD
212.66B INR
Enterprise Value
$2.68BUSD
255.85B INR
Revenue (TTM)
$948.54MUSD
90.82B INR
EBITDA (TTM)
$114.08MUSD
10.88B INR
Net Income (TTM)
-$34.04MUSD
-3.26B INR
EBITDA Margin
12%
Profit Margin
-3.6%
Forward PE
67.4
PS Ratio
2.3
PB Ratio
2.6
EV/EBITDA
21.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
5,476
Founded
2020
Website
piramalpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.1% 6.2% 12% 4% -21% -25%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
PPLPHARMA
Piramal Pharma Ltd
ISIN: INE0DK501011
Shares Out.:
1.329B1 Shares Float: 624.032M2
TV:
SA:
YF:
GF:
BA:
MS:
161.87 INR
Bombay Stock Exchange
MIC: XBOM
543635 (PPLPHARMA)
Piramal Pharma Ltd
ISIN: INE0DK501011
TV:
SA:
YF:
GF:
BA:
MS:
160.15 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Piramal Pharma Ltd.

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
2K%
39.1
DIVISLAB
$18.12B
1.73T INR
716%
70.0
$14.95B
1.43T INR
573%
63.0
$11.57B
1.11T INR
421%
19.6
MANKIND
$9.73B
931.67B INR
338%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
331%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
34K%
38.1
JNJ
$547.28B
25K%
26.4
ABBV
$360.63B
16K%
97.4
$324.68B
256.25B CHF
15K%
19.9
AZN
$289.43B
215.59B GBP
13K%
27.6
NOVN
$277.35B
218.9B CHF
12K%
20.5
chevron_leftBack